|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/137 | (2006.01) |
| A61P 37/00 | (2006.01) | ||
| A61P 37/06 | (2006.01) | ||
| A61K 31/135 | (2006.01) | ||
| A61K 31/138 | (2006.01) | ||
| A61K 31/661 | (2006.01) | ||
| C07F 9/10 | (2006.01) |
| (11) | Number of the document | 2379067 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09797234.3 |
| Date of filing the European patent application | 2009-12-21 | |
| (97) | Date of publication of the European application | 2011-10-26 |
| (45) | Date of publication and mention of the grant of the patent | 2015-09-02 |
| (46) | Date of publication of the claims translation | 2016-02-25 |
| (86) | Number | PCT/US2009/068888 |
| Date | 2009-12-21 |
| (87) | Number | WO 2010/075239 |
| Date | 2010-07-01 |
| (30) | Number | Date | Country code |
| 139672 P | 2008-12-22 | US | |
| 218530 P | 2009-06-19 | US | |
| 246715 P | 2009-09-29 | US |
| (72) |
SCHMOUDER, Robert, US
DUMORTIER, Thomas, CH
DAVID, Olivier, CH
LOOBY, Michael, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Fingolimodo dozavimas, skirtas išsėtinės sklerozės gydymui |
| DOSAGE REGIMEN FOR FINGOLIMOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS |
| Payment date | Validity (years) | Amount | |
| 2015-11-12 | 7 | 162.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2016-10-30 |